Bibliografía del artículo
1. Edwards R. The problem of tobacco smoking. BMJ 328:217-9, 2004.
2. Paiva SAR, Zornoff LAM, Okoshi MP, Okoshi K, Cicogna AC, Campana AO. Behavior of cardiac variables in animals exposed to cigarette smoke. Arq Bras Cardiol 18:225-8, 2003.
3. Castardeli E, Paiva SAR, Matsubara BB e col. A exposição crônica à fumaça do cigarro resulta em remodelação cardíaca e prejuízo da função ventricular em ratos. Arq Bras Cardiol 84:320-4, 2005.
4. Castardeli E, Paiva SAR, Matsubara BB e col. Efeito temporal da exposição à fumaça do cigarro no processo de remodelação ventricular em ratos. Rev Soc Cardiol Estado de São Paulo 15:82, 2005.
5. Paiva SAR, Novo R, Matsubara BB e col. B-carotene attenuates the paradoxical effect of tobacco smoke on the mortality of rats after experimental myocardial infarction. J Nutr 135:2109-3113, 2005.
6. Zornoff LA, Matsubara BB, Matsubara LS e col. A exposição à fumaça do cigarro intensifica a remodelação ventricular após o infarto agudo do miocárdio. Arq Bras Cardiol 86:276-82, 2006.
7. Iwanaga Y, Aoyama T, Kihara Y, Onozawa Y, Yoneda T, Sasayama S. Excessive activation of matriz metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats. J Am Coll Cardiol 39:1384-91, 2002.
8. Deschamps AM, Spinale FG. Pathways of matrix metalloproteinases induction in heart failure: bioactive molecules and transcriptional regulation. Cardiovasc Res 69:666-76, 2006.
9. Jugdutt BI. Matrix metalloproteinases as markers of adverse remodeling after myocardial infarction. J Card Failure 12:73-6, 2006.
10. Janicki JS, Brower GL, Gardner JD e col. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload. Cardiovasc Res 69:657-5, 2006.
11. Castardeli E, Duarte RD, Minicucci MF e col. Tobacco smoke-induced left ventricular remodeling is not associated with metalloproteinase-2 or -9 activation. Eur J Heart Fail, in press.
12. Pryor WA, Church DF, Evans MD, Rice WY, Hayes JR. A comparison of the free radical chemistry of tobacco-burning cigarettes and cigarettes that only heat tobacco. Free Radic Biol Med 8:275-9, 1990.
13. Counts ME, Hsu FS, Laffoon SW, Dwyer RW, Cox RH. Mainstream smoke constituent yields and predicting relationships from a worldwide market sample of cigarette brands: ISO smoking conditions. Regul Toxicol Pharmacol 39:111-34, 2004.
14. Giordano FJ. Oxygen, oxidative stress, hypoxia and heart failure. J Clin Invest 115:500-8, 2005.
15. Sawyer DB, Siwik DA, Xiao J, Pimentel DR, Singh K, Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Moll Cell Cardiol 34:379-88, 2002.
16. Takimoto E, Kass DA. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49:241-8, 2007.
17. Zornoff LA, Matsubara LS, Matsubara BB e col. Beta-carotene supplementation attenuates cardiac remodeling induced by one-month tobacco-smoke exposure in rats. Toxicol Sci 90:259-66, 2006.
18. Grieve DJ, Byrne JA, Cave AC, Shah AM. Role oxidative stress in cardiac remodeling after myocardial infarction. Heart Lung and Circulation 13:132-8, 2004.
19. Udelson JE, Patten RD, Konstam MA. New concepts in post-infarction ventricular remodeling. Rev Cardiovasc Med 4(suppl 3):S3-12, 2003.
20. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 35:569-82, 2000.
21. Litwin SE. The rat model of post infarction heart failure. Heart Failure 11:182-95, 1995.
22. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infracted left ventricle of the rat. Circ Res 57:84-95, 1985.
23. Pfeffer MA, Pfeffer JM, Steinberg BS, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72:406-12, 1985.